Genedrive advances after signing distribution deal with Sysmex Europe
genedrive and Sysmex Europe believe there is a major opportunity to support tackling the global burden of the hepatitis C disease
Company
genedrive PLC
LON:GDR
genedrive plc is a pharmacogenetic testing company developing and commercialising a low cost, rapid, versatile and simple to use point of need pharmacogenetic platform for the diagnosis of genetic variants. This helps clinicians to quickly access key genetic information that will aid them make the right choices over the right medicine or dosage to use for an effective treatment, particularly important in time-critical emergency care healthcare paradigms.
238 stories · page 3 of 3
FTSE 100 closes in negative territory despite resource stock gains
The UK blue chip index closed at 7,526, well below the session peak of 7,557.00 and close to the day’s low of 7,531.48
Archive
UK inflation and jobs data to show real wages remain under pressure
The Week Ahead includes economic data on UK jobs, inflation and retail sales along with full year results from ASOS and Bellway and trading updates from Travis Perkins, Merlin Entertainments, Unilever and Intercontinental Hotels Group
Archive
Proactive news snapshot: ANGLE, Jersey Oil & Gas, Mosman Oil And Gas …
A glance at some of the day's highlights from the Proactive Investors newswire
Zibao Metals shines as it confirms revenue and profit growth this year
Some of the main news-driven risers and fallers at 3.35pm...
Genedrive receives CE mark for its hepatitis C testing kit
The hepatitis C assay provides decentralised molecular testing to support the identification of patients who could benefit from direct acting antiviral therapy
FTSE 100 closes almost 36pts up as traders buy back in
The blue chip index closed out almost 36 points higher at 7,413
Archive
Proactive news snapshot: Goldplat, Eco Atlantic Oil and Gas Keywords, Angle..
Some of today's headlines on the Proactive newswire
Genedrive secures US$1.4mln from US defence department for biohazard-detection device
Genedrive is further developing its handheld device to detect a broader range of biohazard targets
Archive
Proactive news snapshot: Accesso Technology; Nanobiotix; AdEPT Telecom…
A glance at some of the stories on the Proactive newswire today...
Investments and investor services
Sun sets on PV Crystalox Solar's UK operations
Companies featured: Grand Group Investment, PV Crystalox Solar, Thor Mining, Falcon Media House, Game Digital, Proxama, Sports Direct International, Arian Silver Corp, Nu-Oil & Gas, Dart Group
Genedrive making “good progress” as revenues rise across board, Hep-C assay nears EU approval
Genedrive submitted its Genedrive HCV ID kit for CE IVD certification back in March and said today it expects to hear back in the “near future”
Investments and investor services
FTSE 100 closes down a shade with BT Group plc top dog
Footsie was becalmed throughout the day, leaving the mid-cap FTSE 250 to claim the limelight
FTSE 100 ends lower as May makes offer for EU nationals
The UK blue chip index closed down around 15 points at 7,424
Archive
Proactive news round-up: Arian Silver, European Oil & Gas, GeneDrive …
A glance at some of the stories on the Proactive newswire today
Investments and investor services
Red Emperor not amused by continued delays in the Philippines
Red Emperor shares were off 6.3% as the company continues to wait on ratification of its plans to increase its stake in a joint venture.
Genedrive to present data for its Hepatitis-C test at International Liver Conference
Data will be presented to a host of industry professionals at the event in Amsterdam
Investments and investor services
FTSE 100 finishes higher despite North Korea worries hitting US stocks
US markets open lower, but the index of blue-chip shares keeps its poise
Genedrive revenues rise as it waits for EU approval
Genedrive’s HCV assay provides on-the-spot results in just 90 minutes direct from a very small plasma sample.
Genedrive shifts into higher gear as hepatitis C test enters new markets
Regulatory sign-off fires starting pistol on the commercial launch in Europe, Africa, EU Medical Devices Directive awarded CE IVD certification, molecular diagnostics, Europe, Africa, Sysmex
Archive
Proactive news round-up: Hurricane Energy PLC, ITM Power PLC, Genedrive PLC ...
A glance at some of the stories on the Proactive newswire today
Jersey Oil and Gas impresses with Verbier upgrade
Main share price rises and falls at 3.30pm: Jersey Oil and Gas, Beowulf Mining
Diagnostics specialist Genedrive nearing a landmark for breakthrough Hepatitis C test
The receipt of CE IVD certification under the EU Medical Devices Directive would green-light the commercialisation of the product in the European Union.
Genedrive delighted with Hepatitis diagnosis results
The studies were performed at Queen's Medical Centre and Institut Pasteur
Archive
Proactive news highlights: featuring Condor Gold, Genedrive, Porta Comms and more…
Condor Gold reports drilling results from La India; Genedrive making "good progress" in realising potential of breakthrough device; Porta settles Grand Retro debt; and more…
Genedrive making "good progress" in realising the potential of breakthrough device
Chief executive David Budd said: "We are making good progress towards realising the proven potential of the Genedrive platform in a range of applications through our own programmes and partnerships.”
Archive
Proactive news highlights: Hurricane Energy, MySQUAR, Orosur Mining and more…
Hurricane Energy kicks off the Halifax well; MySQUAR user base smashes through the 7.5mln mark; Orosur Mining sees big uptick in profits and cash inflow; plus more…
Genedrive confirms progress with US Department of Justice
Officials will assess the technology's potential to check for hazards such as biological warfare agents.
Genedrive achives its first CE marking for point of care diagnostic test
It has been awarded what’s called CE-IVD certification, that’s the official CE mark for an in-vitro diagnostic medical device.
Genedrive revenues at the top end of expectations
The year has seen us take further significant strides towards realising the potential of the Genedrive platform to bring the strength of hospital-based, central laboratory diagnostics close to the point of need and near patient setting - ch
Proactive news highlights: Cloudtag, Genedrive, Harvest Minerals, Kibo Mining, Midatech and more...
CloudTag raises £580,000, Solo Oil unveils a series of board changes and IronRidge confirms ‘very advanced’ discussions were underway over an investment in a gold prospect in Chad.
Genedrive test to be used in high-profile Hepatitis C clinical trial
The STOP-HCV-1 clinical trial will assess two direct acting anti-viral (DAA) treatment combinations and whether the addition of another, older drug has value in short course treatment
Proactive news highlights: Abzena, Amur Minerals, Falcon Oil & Gas, Michelmersh and more...
Versarien funds a push into graphene-related technologies, Epistem Holdings has been renamed Genedrive and Amur Minerals PLC updates on progress at the giant Kun-Manie nickel project in Russia.